Research output per year
Research output per year
Personal profile
Research interests
My utmost motivation lies in enhancing the safety and effectiveness of cancer immunotherapy, with specific emphasis on personalized neoantigen cancer vaccines.
My research focuses on two main areas:
Define the intrinsic and extrinsic factors that lead to the induction/development of type 1 regulatory T cells and unravel the mechanisms involved in their suppressive activity.
Develop novel vaccination strategies that promote the induction of effector anti-tumor T cells while avoiding the generation of suppressive T-cell responses that promote tumor progression.
Fingerprint
Dive into the research topics where Hussein Sultan is active. These topic labels come from the works of this person and are generated automatically. Together they form a unique fingerprint. Contact the Profiles team with questions.
- 1 Similar Profiles
Collaborations and top research areas from the last five years
Recent external collaboration on country/territory level. Dive into details by clicking on the dots or
-
Cancer Neoantigen Vaccines Emerge Efficacious
Sultan, H. & Schreiber, R. D., 2026, In: Annual review of medicine. 77, 1, p. 297-314 18 p.Research output: Contribution to journal › Review article › peer-review
Open Access -
mRNA vaccines engage unconventional pathways in CD8+ T cell priming
Jo, S., Li, L., Thakur, C., Telfer, K. A., Sultan, H., Ohara, R. A., He, M., Nam, G., Chen, J., Ou, F., Draghi, M., Valiante, N. M., Schreiber, R. D., Randolph, G. J., Saligrama, N., Murphy, T. L., Gillanders, W. E. & Murphy, K. M., Jun 11 2026, In: Nature. 654, 8118, p. 485-494 10 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations -
STAT5 Activation Enhances Adoptive Therapy Combined with Peptide Vaccination by Preventing PD-1 Inhibition
Fan, A. E., Sultan, H., Kumai, T., Fesenkova, V. I., Wu, J., Klement, J. D., Bernstock, J. D., Friedman, G. K. & Celis, E., Mar 1 2025, In: Molecular Cancer Therapeutics. 24, 3, p. 419-430 12 p.Research output: Contribution to journal › Article › peer-review
Open Access1 Link opens in a new tab Scopus citations -
IL2 Targeted to CD8+ T Cells Promotes Robust Effector T-cell Responses and Potent Antitumor Immunity
Moynihan, K. D., Kumar, M. P., Sultan, H., Pappas, D. C., Park, T., Chin, S. M., Bessette, P., Lan, R. Y., Nguyen, H. C., Mathewson, N. D., Ni, I., Chen, W., Lee, Y., Liao-Chan, S., Chen, J., Schumacher, T. N. M., Schreiber, R. D., Yeung, Y. A. & Djuretic, I. M., Jul 1 2024, In: Cancer discovery. 14, 7, p. 1206-1225 20 p.Research output: Contribution to journal › Article › peer-review
Open Access65 Link opens in a new tab Scopus citations -
Improvement of Tumor Neoantigen Detection by High-Field Asymmetric Waveform Ion Mobility Mass Spectrometry
Meng, W., Takeuchi, Y., Ward, J. P., Sultan, H., Arthur, C. D., Mardis, E. R., Artyomov, M. N., Lichti, C. F. & Schreiber, R. D., Aug 2024, In: Cancer immunology research. 12, 8, p. 988-1006 19 p.Research output: Contribution to journal › Article › peer-review
Open Access4 Link opens in a new tab Scopus citations